Department of Internal Medicine, University of Missouri, Columbia, MO 65211, USA.
Arterioscler Thromb Vasc Biol. 2010 Nov;30(11):2156-63. doi: 10.1161/ATVBAHA.110.214700. Epub 2010 Sep 2.
To verify that adiponectin and tumor necrosis factor (TNF)-α reciprocally regulate their expression, thereby synergistically affecting both coronary and aortic endothelial dysfunction in type 2 diabetic mice.
We examined endothelium-dependent and endothelium-independent vasodilation/vasorelaxation of coronary arterioles and aortas in control mice, diabetic mice (Lepr(db)), and Lepr(db) treated with adiponectin or neutralizing antibody to TNF-α (anti-TNF-α). Endothelium-dependent vasodilation to acetylcholine in both coronary arterioles and aortas was blunted in Lepr(db) compared with control mice. Endothelium-independent vasodilation to sodium nitroprusside was comparable. Adiponectin and anti-TNF-α improved acetylcholine-induced vasodilation of coronary arterioles and aortas in Lepr(db) without affecting dilator response to sodium nitroprusside. Adiponectin protein expression was significantly reduced, and TNF-α protein expression was significantly greater, in coronary arterioles and aortas of Lepr(db) compared with control mice. Immunofluorescence staining results indicate that adiponectin was colocalized with endothelial cells. Anti-TNF-α treatment upregulated adiponectin protein expression in Lepr(db) coronary arterioles and aortas. Adiponectin administration reduced TNF-α protein expression in Lepr(db). Although adiponectin receptor 1 protein expression in coronary arterioles and aortas was similar between control and diabetic mice, adiponectin receptor 2 protein expression was significantly reduced in Lepr(db). Both adiponectin and anti-TNF-α inhibited IκBα phosphorylation and nuclear factor κB protein expression in Lepr(db), suggesting that adiponectin and TNF-α signaling may converge on nuclear factor κB to reciprocally regulate their expression.
A reciprocal suppression occurs between adiponectin and TNF-α that fundamentally affects the regulation of coronary and aortic endothelial function in type 2 diabetic mice.
验证脂联素和肿瘤坏死因子 (TNF)-α 相互调节彼此的表达,从而协同影响 2 型糖尿病小鼠的冠状动脉和主动脉内皮功能障碍。
我们检测了对照组小鼠、糖尿病小鼠 (Lepr(db)) 以及接受脂联素或 TNF-α 中和抗体 (anti-TNF-α) 治疗的 Lepr(db) 小鼠的冠状动脉小动脉和主动脉的内皮依赖性和非内皮依赖性血管舒张/松弛反应。与对照组小鼠相比,Lepr(db) 小鼠的冠状动脉小动脉和主动脉对乙酰胆碱的内皮依赖性血管舒张作用减弱。对硝普钠的内皮非依赖性血管舒张作用相当。脂联素和 anti-TNF-α 改善了 Lepr(db) 小鼠冠状动脉小动脉和主动脉对乙酰胆碱诱导的血管舒张作用,而对硝普钠的舒张反应无影响。与对照组小鼠相比,Lepr(db) 小鼠的冠状动脉小动脉和主动脉中的脂联素蛋白表达显著降低,TNF-α 蛋白表达显著增加。免疫荧光染色结果表明,脂联素与内皮细胞共定位。Anti-TNF-α 治疗上调了 Lepr(db) 冠状动脉小动脉和主动脉中的脂联素蛋白表达。脂联素给药降低了 Lepr(db) 中的 TNF-α 蛋白表达。尽管对照组和糖尿病小鼠的冠状动脉小动脉和主动脉中的脂联素受体 1 蛋白表达相似,但 Lepr(db) 中的脂联素受体 2 蛋白表达显著降低。脂联素和 anti-TNF-α 均抑制了 Lepr(db) 中的 IκBα 磷酸化和核因子 κB 蛋白表达,表明脂联素和 TNF-α 信号可能在核因子 κB 上汇聚,以相互调节彼此的表达。
脂联素和 TNF-α 之间存在相互抑制作用,这从根本上影响了 2 型糖尿病小鼠冠状动脉和主动脉内皮功能的调节。